Comparative Study of Sperm Selection Techniques for Pregnancy Rates in an Unselected IVF-ICSI Population.
Ioana ZahaPetronela NaghiLiana StefanCosmina BunescuMihaela RaduMariana Eugenia MuresanMircea SandorSachelarie LilianaAnca C HuniadiPublished in: Journal of personalized medicine (2023)
(1) Background: Semen analysis is a poor predictor of the fertilization potential of spermatozoa and a male factor may contribute to poor outcomes of the IVF procedure, despite a normal semen analysis. The microfluidic sperm selection (ZyMot-ICSI) is based on the selection of the spermatozoa with the lowest DNA fragmentation rate, but studies do not prove better clinical outcomes after this method. (2) Methods: We conducted a retrospective trial comparing 119 couples that were allocated to the classic gradient centrifugation sperm method (control group), and 120 couples that were allocated with the microfluidic technique being used (study group) at our university-level clinic, to go through IVF. (3) Results: The statistical analysis showed that there is no significant difference between the fertilization rate (study vs. control p = 0.87), but regarding blastocyst rate (study vs. control p = 0.046) and clinical pregnancy ( p = 0.049), there is quite a significant statistical difference. Microfluidic preparation of spermatozoa seems to improve the results and it may be utilized more broadly for ICSI, and could also improve the workflow in standard IVF, decrease intervention by laboratory personnel and provide more consistent incubation conditions. (4) Conclusions: The patients that had the sperm preparation for ICSI with the microfluidic sperm selection had slightly better results compared with the gradient centrifugation selection.
Keyphrases
- pregnancy outcomes
- circulating tumor cells
- high throughput
- single cell
- pregnant women
- randomized controlled trial
- primary care
- end stage renal disease
- type diabetes
- study protocol
- label free
- skeletal muscle
- weight loss
- chronic kidney disease
- prognostic factors
- patient reported outcomes
- peritoneal dialysis
- open label
- double blind
- molecularly imprinted
- mass spectrometry
- minimally invasive